Cargando…

Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure

BACKGROUND: Current therapies for anemia of chronic kidney disease (CKD) include administration of supplemental iron (intravenous and/or oral), blood transfusions and replacement of erythropoietin through the administration of recombinant human erythropoietin (rhEPO) and rhEPO analogs, each with lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caltabiano, Stephen, Cizman, Borut, Burns, Olivia, Mahar, Kelly M, Johnson, Brendan M, Ramanjineyulu, Bandi, Serbest, Gulyeter, Cobitz, Alexander R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Anemia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768310/ https://www.ncbi.nlm.nih.gov/pubmed/31583094 http://dx.doi.org/10.1093/ckj/sfz013

Ejemplares similares

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis
por: Meadowcroft, Amy M, et al.
Publicado: (2018)

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease
por: Holdstock, Louis, et al.
Publicado: (2018)

Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function
por: Mahar, Kelly M., et al.
Publicado: (2022)

The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects
por: Caltabiano, Stephen, et al.
Publicado: (2018)

Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination
por: Mahar, Kelly M., et al.
Publicado: (2021)

An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
por: Cizman, Borut, et al.
Publicado: (2018)

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)
por: Macdougall, Iain C., et al.
Publicado: (2023)

Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients
por: Kanai, Hidetoshi, et al.
Publicado: (2021)

The anemias; with special reference to pernicious anemia and the use of liver extracts in the treatment of anemias. Supplement: Blood morphology in diagnosis.
Publicado: (1950)

Evaluation of changes in ferritin levels during sucroferric oxyhydroxide treatment
por: Koiwa, Fumihiko, et al.
Publicado: (2018)

A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis
por: Bailey, Christine K., et al.
Publicado: (2019)

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial
por: Singh, Ajay K., et al.
Publicado: (2022)

Preventing and controlling iron deficiency anaemia through primary health care: a guide for health administrators and programme managers
por: DeMaeyer, E. M.
Publicado: (1989)

A Single‐Dose, Open‐Label, Randomized, Two‐Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat
por: Yamada, Masanori, et al.
Publicado: (2020)

Daprodustat: First Approval
por: Dhillon, Sohita
Publicado: (2020)

Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan
por: Nangaku, Masaomi, et al.
Publicado: (2022)

Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT
por: Devillier, Raynier, et al.
Publicado: (2023)

Eritropoyetina en hematología /
por: Alegre Amor, Adrián
Publicado: (2005)

Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions—A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2019)

Manual de hematología
Publicado: (1998)

Efficacy of Different Doses of Daprodustat for Anemic Non-dialysis Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis
por: Fadlalmola, Hammad, et al.
Publicado: (2022)

Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
por: Ishii, Taisuke, et al.
Publicado: (2021)

ALTERAÇÕES HEMATOLÓGICAS EM PACIENTES COM COVID-19 HOSPITALIZADOS: ESTUDO RETROSPECTIVO
por: Martins, ML, et al.
Publicado: (2021)

Daprodustat: A potential game-changer in renal anemia therapy—A perspective
por: Haider, Muhammad Usman, et al.
Publicado: (2023)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2018)

An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
por: Becker, Kimberly A., et al.
Publicado: (2017)

Daprodustat Accelerates High Phosphate-Induced Calcification Through the Activation of HIF-1 Signaling
por: Tóth, Andrea, et al.
Publicado: (2022)

Anemia y cáncer /
Publicado: (2015)

Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study
por: Iso, Takashi, et al.
Publicado: (2022)

Anemia : hematología para un diagnóstico básico
Publicado: (1986)

Novel approaches to oral iron treatment
por: Moretti, Diego
Publicado: (2019)

Aplastic anemia in adult and pediatric hematology
por: Niemeyer, Charlotte
Publicado: (2019)

The diagnostic potential of the iron-regulatory hormone hepcidin
por: Armitage, Andrew E., et al.
Publicado: (2019)

Mechanisms, mishaps and manipulation of iron uptake
por: Bennett, Cavan, et al.
Publicado: (2019)

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial
por: Singh, Ajay K, et al.
Publicado: (2021)

Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
por: Zheng, Qiyan, et al.
Publicado: (2021)

Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero‐Test bile string
por: Tai, Guoying, et al.
Publicado: (2023)

Risk Factors Before Dialysis Predominate as Mortality Predictors in Diabetic Maintenance Dialysis patients
por: Tsur, Noa, et al.
Publicado: (2019)

Choice of the Dialysis Modality: Practical Considerations
por: Torreggiani, Massimo, et al.
Publicado: (2023)

Dialysis Modality Selection Among Patients Attending Freestanding Dialysis Facilities
por: Kendix, Michael
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_aihh28j6uea8lguq15glmetsov